LEADER 00745nam0-22002771i-450-
001 990005527690403321
005 20050419134157.0
035   $a000552769
035   $aFED01000552769
035   $a(Aleph)000552769FED01
035   $a000552769
100   $a19990604g19--9999km-y0itay50------ba
101 0 $afre
105   $ay-------001yy
200 1 $aNapolèon$fJacques Bainville
210   $a[s.l.]$cAmeric Edit$d19
215   $aV.$d20 cm
676   $a944.05092$v21$zita
700  1$aBainville,$bJacques$f<1879-1936>$0178422
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990005527690403321
952   $a944.05 NAP. 1 (1-2)$bST.MED.MOD. 633$fFLFBC
959   $aFLFBC
996   $aNapoléon$916052
997   $aUNINA

LEADER 01175nam--2200397---450-
001 990002214490203316
005 20050225115948.0
010   $a1-58829-172-3
035   $a000221449
035   $aUSA01000221449
035   $a(ALEPH)000221449USA01
035   $a000221449
100   $a20041125d2004----km-y0enga50------ba
101   $aita
102   $aIT
105   $aa|||z|||001yy
200 1 $aDeath receptors in cancer therapy$fedited by Wafik S. El-Deiry
210   $aTotowa$cHumana Press$d20045
215   $aXI, 374 p.$cill.$d26 cm
225 2 $aCancer drug discovery and development
410  0$12001$aCancer drug discovery and development
454  1$12001
461  1$1001-------$12001
606 0 $aCancro$xAspetti molecolari
606 0 $aCancro$xTerapia
676   $a571.936
702  1$aEL-DEIRY,$bWafik S.
801  0$aIT$bsalbc$gISBD
912   $a990002214490203316
951   $a571.936 DEA$b3971 Farm.$c571.936$d00131640
959   $aBK
969   $aFAR
979   $aACQUISTI$b10$c20041125$lUSA01$h1253
979   $aFIORELLA$b90$c20050225$lUSA01$h1159
996   $aDeath receptors in cancer therapy$91031903
997   $aUNISA